Immature NK cells suppress dendritic cell functions during the development of leukemia in a mouse model

被引:33
作者
Ebata, Kazu
Shimizu, Yukihiro
Nakayama, Yasuhiro
Minemura, Masami
Murakami, Jun
Kato, Tsutomu
Yasumura, Satoshi
Takahara, Terumi
Sugiyama, Toshiro
Saito, Shigeru
机构
[1] Toyama Univ, Fac Med, Dept Internal Med 3, Toyama 9300194, Japan
[2] Toyama Univ, Fac Med, Dept Obstet & Gynecol, Toyama 9300194, Japan
关键词
D O I
10.4049/jimmunol.176.7.4113
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To analyze the mechanisms by which cancer cells escape from hosts' immune surveillance, we investigated the changes in immune status during the progression of leukemia induced by injecting mice with WEHI-3B cells. In the bone marrow (BM) of leukemic mice, only DX5(+)CD3(-) cells were continuously increased, despite the progression of leukemia. In addition, DX5(+)CD3(-) cells were rapidly increased in peripheral blood (PB) 20 days after inoculation. We also found that myeloid dendritic cells (DCs) expressing low levels of I-A(d) and having low allo-T cell stimulatory activity were markedly increased in PB and spleen. The increase in DX5(+) cells in BM was thought to be induced by soluble factors from leukemic cells. DX5(+) cells from leukemic mice were CD3(-), B220(-), Gr-1(-), CD14(-), CD94(-), Ly-49C/F-, asialo GM1(+), CD25(+), CD122(+), Thy-1(bright), and c-kit(dim) and showed low killing activity against YAC-1 cells, suggesting that those DX5(+) cells were immature NK cells. NK cells from leukemic PB down-regulated the expression of I-A(d) on DCs, an effect mediated by TGF-beta. Moreover, these NK cells significantly suppressed the allo-T cell stimulatory activity of DCs, an effect requiring cell-to-cell contact between NK cells and DCs and thought to involve CD25. Importantly, NK cells from leukemic PB inhibited generation of autotumor-specific CTL induced by DCs in primary MLR or by DC immunization. In conclusion, we identified circulating immature NK cells with immunosuppressive activities. These cells may be important for understanding the involvement of the host immune system during the development of leukemia.
引用
收藏
页码:4113 / 4124
页数:12
相关论文
共 47 条
  • [31] Mouse Ly49 NK receptors: balancing activation and inhibition
    Ortaldo, JR
    Young, HA
    [J]. MOLECULAR IMMUNOLOGY, 2005, 42 (04) : 445 - 450
  • [32] Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells
    Piccioli, D
    Sbrana, S
    Melandri, E
    Valiante, NM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (03) : 335 - 341
  • [33] EFFECTS OF THY-1+ CELL DEPLETION ON THE CAPACITY OF DONOR LYMPHOID-CELLS TO INDUCE TOLERANCE ACROSS AN ENTIRE MHC DISPARITY IN SUBLETHALLY IRRADIATED ADULT HOSTS
    PIERCE, GE
    WATTS, LM
    [J]. TRANSPLANTATION, 1989, 48 (02) : 289 - 296
  • [34] Immune inhibitory receptors
    Ravetch, JV
    Lanier, LL
    [J]. SCIENCE, 2000, 290 (5489) : 84 - 89
  • [35] Definition of a novel cellular constituent of the bone marrow that regulates the response of immature B cells to B cell antigen receptor engagement
    Sandel, PC
    Gendelman, M
    Kelsoe, G
    Monroe, JG
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (10) : 5935 - 5944
  • [36] Natural killer cells determine the out-come of B cell-mediated autoimmunity
    Shi, FD
    Wang, HB
    Li, HL
    Hong, S
    Taniguchi, M
    Link, H
    Van Kaer, L
    Ljunggren, HG
    [J]. NATURE IMMUNOLOGY, 2000, 1 (03) : 245 - 251
  • [37] Shimizu Y, 1998, J IMMUNOL, V161, P4520
  • [38] The resistance of P-acnes -: Primed interferon γ-deficient mice to low-dose lipopolysaccharide-induced acute liver injury
    Shimizu, Y
    Margenthaler, JA
    Landeros, K
    Otomo, N
    Doherty, G
    Flye, MW
    [J]. HEPATOLOGY, 2002, 35 (04) : 805 - 814
  • [39] SHIMIZU Y, 1991, CANCER RES, V51, P6153
  • [40] The actin cytoskeleton controls the efficiency of killer Ig-like receptor accumulation at inhibitory NK cell immune synapses
    Standeven, LJ
    Carlin, LM
    Borszcz, P
    Davis, DM
    Burshtyn, DN
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (09) : 5617 - 5625